By KEN MAGUIRE, Fri Mar 31, 4:35 PM ET BOSTON - U.S. and European regulatory approval is the final hurdle for Boston Scientific Corp.'s $27 billion acquisition of Guidant Corp.
http://c.moreover.com/click/here.pl?r499545865
http://c.moreover.com/click/here.pl?r499545865